RAVERUS THERAPEUTICS

WIPO WIPO 2020

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark RAVERUS THERAPEUTICS was filed as Word mark on 06/25/2020 at the World Intellectual Property Organization.

Trademark Details Last update: February 18, 2022

Trademark form Word mark
File reference 1542867
Countries Australia Canada China Colombia European Community United Kingdom Israel India South Korea Mexico New Zealand Russia Singapore Turkey
Base trademark US No. 88758472, January 14, 2020
Application date June 25, 2020
Expiration date February 8, 2021

Trademark owner

Suite 200
3721 Valley Centre Drive
US

Trademark representatives

701 Fifth Avenue, Suite 5400 Seattle WA 98104 US

goods and services

05 Pharmaceutical preparations for the prevention of liver diseases and disorders; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the prevention of kidney diseases and disorders; pharmaceutical preparations for the treatment of kidney diseases and disorders; pharmaceutical preparations for the prevention of central nervous system diseases and disorders; pharmaceutical preparations for the treatment of central nervous system diseases and disorders; pharmaceutical preparations for the prevention of monogenic diseases and disorders; pharmaceutical preparations for the treatment of monogenic diseases and disorders; pharmaceutical preparations for the prevention of metabolic diseases and disorders; pharmaceutical preparations for the treatment of metabolic diseases and disorders; therapeutic preparations for the prevention of liver diseases and disorders; therapeutic preparations for the treatment of liver diseases and disorders; therapeutic preparations for the prevention of kidney diseases and disorders; therapeutic preparations for the treatment of kidney diseases and disorders; therapeutic preparations for the prevention of central nervous system diseases and disorders; therapeutic preparations for the treatment of central nervous system diseases and disorders; therapeutic preparations for the prevention of monogenic diseases and disorders; therapeutic preparations for the treatment of monogenic diseases and disorders; therapeutic preparations for the prevention of metabolic diseases and disorders; therapeutic preparations for the treatment of metabolic diseases and disorders

Trademark history

Date Document number Area Entry
August 20, 2021 2021/36 Gaz US RAW: Total Ceasing Effect
July 29, 2021 2022/7 Gaz JP RAW: Second Part Fee Not Paid
July 29, 2021 2021/30 Gaz JP Rejection
May 24, 2021 2021/21 Gaz RU Rejection
May 19, 2021 2021/25 Gaz IL Rejection
March 19, 2021 2021/12 Gaz NZ Rejection
January 26, 2021 2021/5 Gaz CO Rejection
December 31, 2020 2021/1 Gaz SG Rejection
December 23, 2020 2020/53 Gaz TR Rejection
December 23, 2020 2020/52 Gaz AU Rejection
December 16, 2020 2020/51 Gaz EM Rejection
December 5, 2020 2020/51 Gaz CO Rejection
November 11, 2020 2020/46 Gaz GB Rejection
November 6, 2020 2020/46 Gaz CN Rejection
November 5, 2020 2020/46 Gaz RU Rejection
November 4, 2020 2020/46 Gaz IL Rejection
September 1, 2020 2020/37 Gaz IN Rejection
June 25, 2020 2020/29 Gaz US Registration

ID: 141542867